首页> 外文会议>IT in Medicine and Education (ITME), 2011 International Symposium on >Systemic administration of drag-reducing polymers may be a novel and effective treatment for acute lung injury
【24h】

Systemic administration of drag-reducing polymers may be a novel and effective treatment for acute lung injury

机译:减阻聚合物的全身给药可能是急性肺损伤的一种新颖有效的治疗方法

获取原文

摘要

Over the past several decades, blood-soluble drag reducing polymers DRPs) have been shown to significantly enhance hemodynamics and improve hemorheology in various animal models when added to blood at nanomolar concentrations. Meanwhile, many more researchers appreciate that hemorheology abnormality underlies in acute lung injury (ALI) pathogenesis, especially in neutrophils extravasation mechanism. Therefore, we hypothesize that owing to DRPs' peculiarity to reduce microvascular resistance increase blood flow, and so on, systemic administration of DRPs may be a novel and effective treatment for ALI.
机译:在过去的几十年中,已证明当以纳摩尔浓度添加到血液中时,可溶于血液的减阻聚合物DRPs可显着增强各种动物模型的血流动力学并改善血液流变学。同时,更多的研究者意识到血液流变学异常是急性肺损伤(ALI)发病机制的基础,尤其是在中性粒细胞外渗机制中。因此,我们假设由于DRPs降低微血管阻力的特殊性增加了血流量,等等,全身性给药DRPs可能是ALI的一种新颖有效的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号